<!DOCTYPE html>


<style>
    body{
  background: #18181B;
}

.main{
  font-family: "Noto Sans", ui-sans-serif, system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol", "Noto Color Emoji";
  color: #FDFDFD;
}

h1 {
  font-size: 2.5rem;
  color: white;
}

h3 {
  font-size: 1.5rem;
  background: #0c087c;
  padding: 10px;
  margin: 0px;
  border: 1px solid #6b7280;}

.extended-title{
  width:100%;
}

#gsk-overview{
  display:flex;
}

h4 {
  font-size: 1rem;
  background: #27272A;
  padding: 10px;
  margin: 0px;
  border-bottom: 1px solid #6b7280;
}

h2 {
  font-size: 1.5rem;
  margin-top: 3px;
  color:#000000;
}

.header{
  display: flex;
  justify-content: center;
  align-items: center;
}
.header > * {
  margin-inline: 20px;
}

.flex-row {
  display: flex;
  flex-direction: row;
  padding:10px;
  border: 1px solid #27272A;
}

.flex-row>div {
  flex: auto;
  box-sizing: border-box;
  display: flex;
  flex-direction: column;
  justify-content: center;
  align-items: center;
}

progress[value] {
  --background: #6D6D6D;
  -webkit-appearance: none;
  -moz-appearance: none;
  appearance: none;
  border: none;
  height: 4px;
  margin: 0 10px;
  border-radius: 10em;
  background: var(--background);
}

progress[value]::-webkit-progress-bar {
  border-radius: 10em;
  background: var(--background);
}

progress[value]::-webkit-progress-value {
  border-radius: 10em;
  background: var(--color);
}

progress[value]::-moz-progress-bar {
  border-radius: 10em;
  background: var(--color);
}

label {
  font-size: 20px;
  font-weight: bold;
  display: block;
  margin: 20px 0;
}

.tab {
  overflow: hidden;
  border: 1px solid #27272A;
  background-color: #27272A;
}

.tab button {
  background-color: inherit;
  float: left;
  border: none;
  outline: none;
  cursor: pointer;
  padding: 14px 16px;
  transition: 0.3s;
  color: #ffffff;
  font-size:1.2rem;
}

.tab div {
  background-color: inherit;
  float: left;
  border: none;
  outline: none;
  cursor: pointer;
  padding: 14px 16px;
  transition: 0.3s;
  color: #ffffff;
  font-size: 1.2rem;
}

.tab button:hover {
  background-color: #18181B;
}

.tab-title{
  font-size: 1.5rem;
  font-weight: bold;
  margin-bottom:-5px;
}

.tab button.active {
  background-color: #18181B;
  border-top: 1px solid #6b7280;
  border-bottom: 1px solid #18181B;
  border-left: 1px solid #6b7280;
  border-right: 1px solid #6b7280;
}

.tabcontent {
  display: none;
  padding: 6px 12px;
  background: #18181B;
  border: 1px solid #27272A;
  border-top: 1px solid #6b7280;
  margin-top: -2px;
}

#gsk-advice {
  display: flex;
  justify-content: center;
}

#gsk-metrics{
  width:100%;
}

#recommendation {
  margin-top: 20px;
  padding: 20px;
  border-radius: 10px;
  background-color: #e1ce86;
  color: #27272A;
  width:95%;
  box-shadow: 0 4px 8px 0 #000000, 0 6px 20px 0 #000000;
  font-size: 12pt;
}

.separator {
  margin: 20px 0;
}

.separator-border {
  margin: 20px 0;
  border-bottom: 1px solid #6b7280;
}

#gsk-rag{
  margin: 32px 28px;
  padding: 12px 24px;
  background-color: #111516;
}

.section-container {
  margin-bottom: 32px;
}

  .components-container {
    display: flex;
    flex-flow: row wrap;
    align-items: flex-start;
    gap: 0 32px;
  }

    .component-card {
      background-color: #14191B;
      border-radius: 16px;
      padding: 28px 32px 32px 32px;
      display: flex;
      flex-flow: column;
      align-items: center;
      margin-top: 32px;
      flex-grow: 1;
    }

    .component-title {
      font-size: 12px;
      font-weight: 500;
      color: #B1B1B1;
      padding-bottom: 8px;
    }

    .component-value {
      font-size: 32px;
      font-weight: 500;
      padding-bottom: 12px;
    }
      
      .text-green {
        color: #04B543;
      }
      
      .text-orange {
        color: #E76E0F;
      }
      
      .text-red {
        color: #EA3829;
      }

      .tooltip {
        position: relative;
        display: inline-block;
      }

      .tooltip .tooltiptext {
        visibility: hidden;
        width: 120px;
        background-color: #464646;
        color: #E6E6E6;
        text-align: center;
        border-radius: 6px;
        position: absolute;
        z-index: 1;
        top: 150%;
        left: 50%;
        margin-left: -60px;
        font-size: 12px;
        padding: 12px;
      }
      
      .tooltip .tooltiptext::after {
        content: "";
        position: absolute;
        bottom: 100%;
        left: 50%;
        margin-left: -5px;
        border-width: 5px;
        border-style: solid;
        border-color: transparent transparent black transparent;
      }
      
      .tooltip:hover .tooltiptext {
        visibility: visible;
      }

    .overall-card {
      background-color: #026836;
      border-radius: 16px;
      padding: 28px 32px 32px 32px;
      display: flex;
      flex-flow: column;
      align-items: center;
      justify-content: center;
      margin-top: 32px;
      flex-grow: 1;
    }
  
    .overall-title {
      font-size: 12px;
      font-weight: 500;
      color: #E6E6E6;
      padding: 14px 0 8px 0;
      text-transform: uppercase;
     }
  
    .overall-value {
      font-size: 32px;
      font-weight: 500;
      padding-bottom: 12px;
      color: #E6E6E6;
    }

.section-title {
  font-size: 12px;
  color: #B1B1B1;
  margin-bottom: 20px;
  text-align: left;
  width: 100%;
}

.section-content {
  color: #E6E6E6;
  font-size: 20px;
  line-height: 1.5;
}

.section-card {
  background-color: #14191B;
  border-radius: 16px;
  padding: 28px 32px 32px 32px;
  display: flex;
  flex-flow: column;
  align-items: center;
}

.correctness-indicator{
  padding: 20px;
  border-radius: 50px;
  font-size: 16pt;
  box-shadow: 0 4px 8px 0 #000000, 0 6px 20px 0 #000000;
  text-align: center;
}

.metric-title{
  margin: -2px;
  border-bottom: none;
}

.hist-row {
  display: flex;
  flex-direction: row;
  padding: 10px;
  justify-content: space-around;
  width: 85%;
}

.hist-row>div {
  flex: auto;
  box-sizing: border-box;
  display: flex;
  flex-direction: column;
  justify-content: center;
  align-items: center;
  padding-left: 1%;
  padding-right: 1%;
}

.tab-row{
  display: flex;
  flex-direction: column;
  align-items: center;
}

#component-table{
  width:50%;
  margin-top: 10px;
}

.green{
  background-color: #0a980a;
}

.orange {
  background-color: #e5b62a;
}

.red {
  background-color: #ba0e0e;
}

.progress-green {
  --color: #04B543;
}

.progress-orange {
  --color: #E76E0F;
}

.progress-red {
  --color: #EA3829;
}

.corr-plot{
  flex: 1;
  padding-left: 2%;
}

.tooltip-text {
  position: absolute;
  display: none;
  visibility: hidden;
  z-index: 1;
  top: 100%;
  left: 0%;
  width: 100%;
  color: white;
  font-size: 12px;
  background-color: #2d3d4c;
  border-radius: 10px;
  padding: 10px 15px 10px 15px;
}

#fade {
  opacity: 1;
  transition: opacity 0.5s;
}

#delay {
  opacity: 0;
  transition: opacity 0.2s;
  transition-delay: 1s;
}

td {
  position: relative;
}

tr:hover .tooltip-text {
  display: block;
  visibility: visible;
}

.tr:hover #fade {
  opacity: 1;
}

.tr:hover #delay {
  opacity: 1;
}

.callout {
  padding: 0.5rem 1rem 0.5rem 3rem;
  background: #D9EDF9;
  border: 3px solid #0088D1;
  color: #272eb5;
  position: relative;
  max-width: 40rem;
  border-radius: 10px;
  margin-top: 10%;
  font-size: 11pt;
}

.callout-icon {
  content: "";

  /* SVG via a data URI! */
  background-size: cover;
  width: 1.5rem;
  height: 1.5rem;
  display: block;
  position: absolute;
  left: 0.9rem;
  top: 1.1rem;
}

.callout-icon svg{
  fill: #016ca7;
}
.callout p+p {
  margin-top: 1em;
}

.callout a {
  color: #272eb5;
  font-weight: bold;
}

#gsk-logo {
  padding-top: 10px;
}
</style>
<script src="https://cdn.bokeh.org/bokeh/release/bokeh-3.3.4.min.js" integrity="sha384-5QIrjQuyo4I/x6DK/Sau33lcA3hT2TCZGr9vbk+2ebd7Da6FnR1amdM+9B5xOrSf" crossorigin="anonymous"></script>
<script src="https://cdn.bokeh.org/bokeh/release/bokeh-gl-3.3.4.min.js" integrity="sha384-tXTWPp/bAKa+K9RPuXh7DNvye0Mv+P+6y4rAMVy+pWapsnXg9UG7g20WZ0N4i28A" crossorigin="anonymous"></script>





<div class="main">
    <div id="gsk-rag" class="dark:text-white dark:bg-zinc-800 rounded border border-gray-500">
        <div class="header border-b border-b-gray-500">
            
                <svg xmlns="http://www.w3.org/2000/svg" width="60" height="30" viewBox="0 0 30 15" fill="none" id="gsk-logo">
                    <path fill="#fff" fill-rule="evenodd"
                        d="M22.504 1.549a4.196 4.196 0 0 1 2.573-.887v.002a3.783 3.783 0 0 1 2.706 1.086 3.783 3.783 0 0 1 1.126 2.69 3.771 3.771 0 0 1-1.126 2.69 3.77 3.77 0 0 1-2.706 1.085l-4.794.011-2.533 3.467L8.203 15l2.881-3.335a9.829 9.829 0 0 1-4.663-1.68H3.185L0 7.163h3.934C4.263 3.165 8.187 0 12.96 0c2.24 0 4.489.696 6.175 1.909a7.423 7.423 0 0 1 1.882 1.919 4.194 4.194 0 0 1 1.487-2.28ZM7.05 3.249l3.91 3.915h1.505L7.89 2.584a7.773 7.773 0 0 0-.84.665Zm4.079-2.008 5.923 5.923h1.503l-6.086-6.087c-.45.023-.898.078-1.34.164ZM4.574 8.226h-1.77l.784.693h1.584a8.454 8.454 0 0 1-.598-.693Zm9.479 0H5.984c1.469 1.477 3.656 2.377 5.977 2.422l2.092-2.422Zm-2.458 4.472 5.492-1.902 1.878-2.569h-3.508l-3.862 4.47Zm10.361-5.552h3.265a2.714 2.714 0 0 0 1.747-4.648 2.711 2.711 0 0 0-1.888-.773 3.127 3.127 0 0 0-3.123 3.124v2.297Zm3.659-3.73a.677.677 0 1 1-.134 1.348.677.677 0 0 1 .134-1.348Z"
                        clip-rule="evenodd" />
                </svg>
            <h1>RAG Evaluation Toolkit</h1>
        </div>
        
        <div class="section-container">
            <div class="components-container">
                
                <div class="component-card">
                    <div class="component-title">GENERATOR</div>
                    <div class="component-value tooltip  text-orange ">
                        30.0%
                            <span class="tooltiptext" id="fade">The Generator is the LLM inside the RAG to generate the answers.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=30.000000000000004 class=" progress-orange ">30.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">RETRIEVER</div>
                    <div class="component-value tooltip  text-orange ">
                        50.0%
                            <span class="tooltiptext" id="fade">The Retriever fetches relevant documents from the knowledge base according to a user query.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=50.0 class=" progress-orange ">50.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">REWRITER</div>
                    <div class="component-value tooltip  text-red ">
                        16.67%
                            <span class="tooltiptext" id="fade">The Rewriter modifies the user query to match a predefined format or to include the context from the chat history.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=16.666666666666664 class=" progress-red ">16.67%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">ROUTING</div>
                    <div class="component-value tooltip  text-green ">
                        100.0%
                            <span class="tooltiptext" id="fade">The Router filters the query of the user based on his intentions (intentions detection).</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=100.0 class=" progress-green ">100.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">KNOWLEDGE_BASE</div>
                    <div class="component-value tooltip  text-green ">
                        100.0%
                            <span class="tooltiptext" id="fade">The knowledge base is the set of documents given to the RAG to generate the answers. Its scores is computed differently from the other components: it is the difference between the maximum and minimum correctness score across all the topics of the knowledge base.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=100.0 class=" progress-green ">100.0%</progress>
                    </div>
                </div>
                
                <div class="overall-card">
                    <div class="overall-title">Overall Correctness Score</div>
                    <div class="overall-value">30%</div>
                </div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">RECOMMENDATION</div>
                <span class="section-content">Focus on improving the performance on complex and conversational questions by refining the Generator component to handle more nuanced and contextual inquiries.</span>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">CORRECTNESS BY TOPIC</div>
                    <script type="text/javascript">
        (function() {
  const fn = function() {
    Bokeh.safely(function() {
      (function(root) {
        function embed_document(root) {
        const docs_json = '{"c26618df-bfa8-4d8f-ad68-f061c927d744":{"version":"3.4.3","title":"Bokeh Application","roots":[{"type":"object","name":"Figure","id":"p1411","attributes":{"height":350,"width_policy":"max","x_range":{"type":"object","name":"DataRange1d","id":"p1413","attributes":{"start":0}},"y_range":{"type":"object","name":"FactorRange","id":"p1420","attributes":{"factors":["Others"]}},"x_scale":{"type":"object","name":"LinearScale","id":"p1421"},"y_scale":{"type":"object","name":"CategoricalScale","id":"p1422"},"title":{"type":"object","name":"Title","id":"p1418","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p1440","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p1408","attributes":{"selected":{"type":"object","name":"Selection","id":"p1409","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p1410"},"data":{"type":"map","entries":[["correctness",{"type":"ndarray","array":{"type":"bytes","data":"AAAAAAAAPkA="},"shape":[1],"dtype":"float64","order":"little"}],["metadata_values",["Others"]],["colors",["#a50026"]]]}}},"view":{"type":"object","name":"CDSView","id":"p1441","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p1442"}}},"glyph":{"type":"object","name":"HBar","id":"p1437","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"fill_color":{"type":"value","value":"#14191B"}}},"nonselection_glyph":{"type":"object","name":"HBar","id":"p1438","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"line_alpha":{"type":"value","value":0.1},"fill_color":{"type":"value","value":"#14191B"},"fill_alpha":{"type":"value","value":0.1},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"HBar","id":"p1439","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"#14191B"},"fill_alpha":{"type":"value","value":0.2},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p1449","attributes":{"data_source":{"id":"p1408"},"view":{"type":"object","name":"CDSView","id":"p1450","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p1451"}}},"glyph":{"type":"object","name":"HBar","id":"p1446","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"HBar","id":"p1447","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.1},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"HBar","id":"p1448","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.2},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p1459","attributes":{"visible":false,"data_source":{"type":"object","name":"ColumnDataSource","id":"p1453","attributes":{"selected":{"type":"object","name":"Selection","id":"p1454","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p1455"},"data":{"type":"map","entries":[["x",[0]],["y",[0]]]}}},"view":{"type":"object","name":"CDSView","id":"p1460","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p1461"}}},"glyph":{"type":"object","name":"Line","id":"p1456","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_width":2,"line_dash":[6]}},"nonselection_glyph":{"type":"object","name":"Line","id":"p1457","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_alpha":0.1,"line_width":2,"line_dash":[6]}},"muted_glyph":{"type":"object","name":"Line","id":"p1458","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_alpha":0.2,"line_width":2,"line_dash":[6]}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p1419","attributes":{"tools":[{"type":"object","name":"HoverTool","id":"p1433","attributes":{"renderers":"auto","tooltips":[["topic","@metadata_values"],["Correctness","@correctness{0.00}"]]}}]}},"toolbar_location":null,"left":[{"type":"object","name":"CategoricalAxis","id":"p1428","attributes":{"ticker":{"type":"object","name":"CategoricalTicker","id":"p1429"},"formatter":{"type":"object","name":"CategoricalTickFormatter","id":"p1430"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p1431"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p1423","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p1424","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p1425"},"axis_label":"Correctness (%)","axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p1426"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p1427","attributes":{"axis":{"id":"p1423"},"grid_line_color":"#E0E0E0","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p1432","attributes":{"dimension":1,"axis":{"id":"p1428"},"grid_line_color":"#E0E0E0","grid_line_alpha":0.25}},{"type":"object","name":"Span","id":"p1452","attributes":{"location":30.0,"dimension":"height","line_color":"#EA3829","line_width":2,"line_dash":[6]}},{"type":"object","name":"Legend","id":"p1462","attributes":{"border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p1463","attributes":{"label":{"type":"value","value":"Correctness on the entire Testset"},"renderers":[{"id":"p1459"}]}}]}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}]}}';
        const render_items = [{"docid":"c26618df-bfa8-4d8f-ad68-f061c927d744","roots":{"p1411":"d17cf620-4c5d-4f5c-87a6-a22f07fd56a9"},"root_ids":["p1411"]}];
        root.Bokeh.embed.embed_items(docs_json, render_items);
        }
        if (root.Bokeh !== undefined) {
          embed_document(root);
        } else {
          let attempts = 0;
          const timer = setInterval(function(root) {
            if (root.Bokeh !== undefined) {
              clearInterval(timer);
              embed_document(root);
            } else {
              attempts++;
              if (attempts > 100) {
                clearInterval(timer);
                console.log("Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing");
              }
            }
          }, 10, root)
        }
      })(window);
    });
  };
  if (document.readyState != "loading") fn();
  else document.addEventListener("DOMContentLoaded", fn);
})();
    </script>

                <div id="d17cf620-4c5d-4f5c-87a6-a22f07fd56a9" data-root-id="p1411" style="display: contents;"></div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">KNOWLEDGE BASE OVERVIEW</div>
                    <script type="text/javascript">
        (function() {
  const fn = function() {
    Bokeh.safely(function() {
      (function(root) {
        function embed_document(root) {
        const docs_json = '{"6310f847-ff16-4bca-a752-c47d52ed6673":{"version":"3.4.3","title":"Bokeh Application","roots":[{"type":"object","name":"Tabs","id":"p1344","attributes":{"sizing_mode":"stretch_width","tabs":[{"type":"object","name":"TabPanel","id":"p1281","attributes":{"title":"Topic exploration","child":{"type":"object","name":"Figure","id":"p1236","attributes":{"sizing_mode":"stretch_width","x_range":{"type":"object","name":"Range1d","id":"p1245","attributes":{"start":18.41229381561279,"end":23.148610305786132}},"y_range":{"type":"object","name":"Range1d","id":"p1246","attributes":{"start":9.936155080795288,"end":15.143378496170044}},"x_scale":{"type":"object","name":"LinearScale","id":"p1247"},"y_scale":{"type":"object","name":"LinearScale","id":"p1248"},"title":{"type":"object","name":"Title","id":"p1243","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p1276","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p1233","attributes":{"selected":{"type":"object","name":"Selection","id":"p1234","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p1235"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"uiucQTZfqkG15KBB/ZyjQdDgpEGFLJtBF2mrQQO+o0FRcpRB7nqVQQ=="},"shape":[10],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"LwFcQa7NV0GMeE9B45U+QUTfY0EJ3T1BNBI/QUrdLEGlx0tBe2hkQQ=="},"shape":[10],"dtype":"float32","order":"little"}],["topic",["Others","Others","Others","Others","Others","Others","Others","Others","Others","Others"]],["id",[0,1,2,3,4,5,6,7,8,9]],["content",["ATRIPLA ACCESS- efavirenz, emtricitabine, and tenofovir disoproxil\\nfumarate tablet, film coated \\n \\nGilead Sciences, Inc.\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use ATRIPLA safely and\\neffectively. See full prescribing information for ATRIPLA.\\nATRIPLA\\u2122 (efavirenz, emtricitabine, and tenofovir disoproxil fumarate) tablets, for oral use\\nGILEAD ACCESS PROGRAM\\nInitial U.S. Approval: 2006\\nWARNING: POSTTREATMENT ACUTE EXACERBATION O...","ADVIL- ibuprofen tablet, coated \\n \\nHaleon US Holdings LLC\\n----------\\nDrug Facts\\nActive Ingredient\\nAdvil Tablets (in each tablet)\\nIbuprofen 200 mg (NSAID)*\\n*nonsteroidal anti-inflammatory drug\\nAdvil Caplets (in each caplet)\\nIbuprofen 200 mg (NSAID)*\\n*nonsteroidal anti-inflammatory drug\\nAdvil Gel Caplets (in each gel caplet)\\nIbuprofen 200 mg (NSAID)*\\n*nonsteroidal anti-inflammatory drug\\nPurpose\\nPain reliever/Fever reducer\\nUses\\ntemporarily relieves minor aches and pains due to:\\nheadache\\ntoothache\\nb...","LIPITOR- atorvastatin calcium tablet, film coated \\n \\nParke-Davis Div of Pfizer Inc\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use LIPITOR safely and\\neffectively. \\nSee full prescribing information for LIPITOR.\\n \\nLIPITOR\\u00ae (atorvastatin calcium) tablets, for oral use\\nInitial U.S. Approval: 1996\\nRECENT MAJOR CHANGES\\nContraindications, Pregnancy and Lactation (\\n4\\n)          Removed 12/2022\\nWarnings and Precautions, CNS Toxicity (\\n5.5...","METFORMIN HYDROCHLORIDE- metformin hydrochloride tablet \\n \\nAmneal Pharmaceuticals LLC\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use \\nMETFORMIN\\nHYDROCHLORIDE TABLETS\\n safely and effectively. See full prescribing information for\\nMETFORMIN HYDROCHLORIDE TABLETS\\n. \\n \\nMETFORMIN HYDROCHLORIDE\\n tablets, for oral use \\nInitial U.S. Approval: 1995\\nWARNING: LACTIC ACIDOSIS\\nSee full prescribing information for complete boxed warning.\\nPostm...","NORVASC- amlodipine besylate tablet \\n \\nPFIZER LABORATORIES DIV PFIZER INC\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use NORVASC safely and\\neffectively. See full prescribing information for NORVASC. \\n \\nNORVASC\\n (amlodipine besylate) Tablets for oral administration \\nInitial U.S. Approval: 1992\\nINDICATIONS AND USAGE\\nNORVASC is a calcium channel blocker and may be used alone or in combination with other\\nantihypertensive and antiang...","LOPRESSOR- metoprolol tartrate tablet \\n \\nValidus Pharmaceuticals LLC\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use \\nLOPRESSOR\\n safely and\\neffectively. See full prescribing information for \\nLOPRESSOR\\n. \\n      \\n \\nLOPRESSOR\\n (metoprolol \\ntart\\nr\\nate\\n) \\nt\\nablet\\ns\\n,\\n for \\no\\nral \\nu\\nse\\n \\nInitial U.S. Approval: \\n1992\\n \\nINDICATIONS AND USAGE\\nLOPRESSOR is a beta-adrenergic blocker indicated for the treatment of:\\nHypertension, to lower blo...","ALBUTEROL SULFATE- albuterol sulfate solution \\n \\nIngenus Pharmaceuticals, LLC\\n----------\\nAlbuterol Sulfate Inhalation Solution \\n0.63 mg*/3 mL and 1.25 mg*/3 mL \\n(*Equivalent to 0.75 mg of albuterol sulfate or 1.5 mg of albuterol sulfate per\\n3 mL)\\nPRESCRIBING INFORMATION\\nDESCRIPTION\\nAlbuterol sulfate inhalation solution is a sterile, clear, colorless solution of the sulfate salt\\nof racemic albuterol, albuterol sulfate. Albuterol sulfate is a relatively selective beta \\n-\\nadrenergic bronchodilator ...","INSULIN DEGLUDEC- insulin degludec injection, solution \\n \\nNovo Nordisk Pharma, Inc.\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use INSULIN DEGLUDEC safely\\nand effectively. \\nSee full prescribing information for INSULIN DEGLUDEC.\\nINSULIN DEGLUDEC injection, for subcutaneous use\\nInitial U.S. Approval: 2015\\nThis product is Tresiba (insulin degludec).\\nINDICATIONS AND USAGE\\nInsulin Degludec is a long-acting human insulin analog indica...","ZOLOFT- sertraline hydrochloride tablet, film coated \\n \\nZOLOFT- sertraline hydrochloride solution, concentrate \\n \\nROERIG\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use ZOLOFT safely and\\neffectively. \\nSee full prescribing information for ZOLOFT.\\n \\nZOLOFT (sertraline hydrochloride) tablets, for oral use\\nZOLOFT (sertraline hydrochloride) oral solution\\nInitial U.S. Approval: 1991\\nWARNING: SUICIDAL THOUGHTS AND BEHAVIORS\\nSee full pre...","ATOVAQUONE AND PROGUANIL HCL- atovaquone and proguanil\\nhydrochloride tablet, film coated \\n \\nA-S Medication Solutions\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use Atovaquone and\\nProguanil Hydrochloride safely and effectively. See full prescribing information for\\nAtovaquone and Proguanil Hydrochloride.\\nAtovaquone and Proguanil Hydrochloride tablets\\nInitial U.S. Approval: 2000\\nINDICATIONS AND USAGE\\nAtovaquone and Proguanil Hydroc..."]],["color",{"type":"ndarray","array":["#999","#999","#999","#999","#999","#999","#999","#999","#999","#999"],"shape":[10],"dtype":"object","order":"little"}]]}}},"view":{"type":"object","name":"CDSView","id":"p1277","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p1278"}}},"glyph":{"type":"object","name":"Scatter","id":"p1273","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.7},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p1274","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p1275","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.2}}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p1244","attributes":{"logo":"grey","tools":[{"type":"object","name":"HoverTool","id":"p1259","attributes":{"renderers":"auto","tooltips":"\\n    &lt;div style=\\"width:400px;\\"&gt;\\n    &lt;b&gt;Document id:&lt;/b&gt; @id &lt;br&gt;\\n    &lt;b&gt;Topic:&lt;/b&gt; @topic &lt;br&gt;\\n    &lt;b&gt;Document Content:&lt;/b&gt; @content\\n    &lt;/div&gt;\\n    "}},{"type":"object","name":"PanTool","id":"p1260"},{"type":"object","name":"WheelZoomTool","id":"p1261","attributes":{"renderers":"auto"}},{"type":"object","name":"BoxZoomTool","id":"p1262","attributes":{"overlay":{"type":"object","name":"BoxAnnotation","id":"p1263","attributes":{"syncable":false,"level":"overlay","visible":false,"left":{"type":"number","value":"nan"},"right":{"type":"number","value":"nan"},"top":{"type":"number","value":"nan"},"bottom":{"type":"number","value":"nan"},"left_units":"canvas","right_units":"canvas","top_units":"canvas","bottom_units":"canvas","line_color":"black","line_alpha":1.0,"line_width":2,"line_dash":[4,4],"fill_color":"lightgrey","fill_alpha":0.5}}}},{"type":"object","name":"ResetTool","id":"p1268"},{"type":"object","name":"SaveTool","id":"p1269"}]}},"left":[{"type":"object","name":"LinearAxis","id":"p1254","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p1255","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p1256"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p1257"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p1249","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p1250","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p1251"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p1252"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p1253","attributes":{"axis":{"id":"p1249"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p1258","attributes":{"dimension":1,"axis":{"id":"p1254"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Legend","id":"p1279","attributes":{"title":"Knowledge Base Tospics","title_text_color":"#B1B1B1","title_text_font_style":"bold","border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p1280","attributes":{"label":{"type":"value","value":"Others"},"renderers":[{"id":"p1276"}],"index":0}}]}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}}},{"type":"object","name":"TabPanel","id":"p1343","attributes":{"title":"Failures","child":{"type":"object","name":"Figure","id":"p1286","attributes":{"sizing_mode":"stretch_width","x_range":{"type":"object","name":"Range1d","id":"p1295","attributes":{"start":18.41229381561279,"end":23.148610305786132}},"y_range":{"type":"object","name":"Range1d","id":"p1296","attributes":{"start":9.936155080795288,"end":15.143378496170044}},"x_scale":{"type":"object","name":"LinearScale","id":"p1297"},"y_scale":{"type":"object","name":"LinearScale","id":"p1298"},"title":{"type":"object","name":"Title","id":"p1293","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p1325","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p1282","attributes":{"selected":{"type":"object","name":"Selection","id":"p1283","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p1284"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"/ZyjQdDgpEFRcpRBF2mrQVFylEHuepVBhSybQf2co0H9nKNBUXKUQQ=="},"shape":[10],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"45U+QUTfY0Glx0tBNBI/QaXHS0F7aGRBCd09QeOVPkHjlT5BpcdLQQ=="},"shape":[10],"dtype":"float32","order":"little"}],["topic",["Others","Others","Others","Others","Others","Others","Others","Others","Others","Others"]],["correctness",[false,true,false,false,false,true,true,false,false,false]],["questions",["What is the initial U.S. approval year for Metformin Hydrochloride tablets?","What is the recommended starting dose for adults when using NORVASC for hypertension?","What specific warning is highlighted in the prescribing information for ZOLOFT that relates to suicidal thoughts and behaviors in pediatric and young adult patients?","What is the recommended method for administering Albuterol sulfate inhalation solution without the need for dilution prior to nebulization?","What caution should be taken regarding ZOLOFT for patients in terms of suicidal thoughts and behaviors, as mentioned in the prescribing information?","What is the recommended dosage of Atovaquone and Proguanil Hydrochloride tablets for adults with respiratory conditions?","I&#x27;m learning about LOPRESSOR for hypertension. Can you tell me what are the common adverse reactions associated with LOPRESSOR (metoprolol tartrate) tablets?","I am experiencing symptoms of malaise, myalgias, and abdominal pain after taking Metformin Hydrochloride tablets. When did Metformin Hydrochloride tablets receive initial U.S. approval?","What is the initial U.S. approval year for Metformin Hydrochloride tablets and what is the recommended starting dose for pediatric patients?","What is that?"]],["agent_answer",["The provided context discusses Atovaquone and Proguanil Hydrochloride tablets, not Metformin Hydrochloride tablets. The initial U.S. approval year for Atovaquone and Proguanil Hydrochloride tablets is mentioned as **2000** in the document title metadata.  \\n\\nFor information on Metformin Hydrochloride tablets, I&#x27;d need relevant context or documentation specific to that medication. Let me know if you&#x27;d like assistance with Atovaquone and Proguanil Hydrochloride or if you can provide details about Metformin Hydrochloride!","Based on the provided context documents, the medication discussed is **Atovaquone and Proguanil Hydrochloride** (used for malaria prevention/treatment), **not NORVASC (amlodipine)** for hypertension.  \\n\\nHowever, to directly address your question (though outside the given context):  \\nThe typical **starting dose for NORVASC (amlodipine) in adults with hypertension** is **5 mg once daily**, which may be increased to a maximum of **10 mg daily** based on individual response.  \\n\\n*Note: Always consult a healthcare provider for personalized dosing.*  \\n\\nLet me know if you&#x27;d like details on **Atovaquone and Proguanil Hydrochloride** from the provided documents.","The provided context does not contain information about Zoloft (sertraline) or its prescribing warnings regarding suicidal thoughts and behaviors in pediatric/young adult patients. The documents exclusively discuss **Atovaquone and Proguanil Hydrochloride**, an antimalarial medication, including its indications, adverse effects (e.g., gastrointestinal/hepatic reactions), drug interactions, and usage in specific populations.  \\n\\nHowever, if you&#x27;d like details about **Atovaquone and Proguanil Hydrochloride**, let me know! For Zoloft warnings, I\\u2019d need the correct prescribing information for that specific drug.  \\n\\n*(Note: Always refer to the latest prescribing information for accuracy.)*","The provided context documents detail information about **Atovaquone and Proguanil Hydrochloride** (for malaria prevention/treatment), not **Albuterol sulfate inhalation solution**. Therefore, the documents do not contain any guidance on administering Albuterol sulfate or nebulization methods.  \\n\\nFor accurate information on **Albuterol sulfate inhalation solution**, consult its official prescribing information or guidelines. Let me know if you&#x27;d like assistance locating that specific resource!  \\n\\n*Always follow the prescribing instructions for the correct medication in question.*","Apologies, but the provided context does not contain any information about Zoloft (sertraline) or its prescribing details regarding suicidal thoughts and behaviors. The documents focus exclusively on **Atovaquone and Proguanil Hydrochloride** (an antimalarial drug), including its adverse effects (e.g., gastrointestinal, hepatic, and skin reactions), drug interactions (e.g., with rifampin, anticoagulants), and warnings (e.g., contraindications in severe renal impairment).  \\n\\nIf you&#x27;d like information about **Zoloft&#x27;s** boxed warning for suicidal ideation in certain populations, I\\u2019d be happy to provide a general overview based on my knowledge (last updated January 2025). Let me know how you&#x27;d like to proceed!  \\n\\nFor accuracy regarding **Atovaquone and Proguanil Hydrochloride**:  \\n- Key warnings include **hepatic failure risk**, **vomiting/diarrhea reducing efficacy**, and **avoidance in severe renal impairment**.  \\n- No mention of suicidality or psychiatric effects is made in the context.  \\n\\nWould you like details on any of these points?","The provided prescribing information for **Atovaquone and Proguanil Hydrochloride tablets** does not specify a recommended dosage for adults with **respiratory conditions**. The document outlines dosages for two primary uses:  \\n1. **Prophylaxis (prevention) of malaria**:  \\n   - Adults: **One adult-strength tablet (250 mg atovaquone/100 mg proguanil HCl) daily**.  \\n   - Taken 1\\u20132 days before travel, during the stay, and for 7 days after leaving the malaria-endemic area.  \\n\\n2. **Treatment of acute, uncomplicated malaria**:  \\n   - Adults: **Four adult-strength tablets (total 1 g atovaquone/400 mg proguanil HCl) as a single daily dose for 3 consecutive days**.  \\n\\n### Key Notes:  \\n- The document does not mention respiratory conditions (e.g., asthma, COPD) as an indication for this drug. Atovaquone/proguanil is specifically approved for malaria prevention/treatment.  \\n- If respiratory conditions coexist (e.g., a traveler with asthma needing malaria prophylaxis), standard dosing applies unless contraindicated (e.g., severe renal impairment).  \\n- For off-label use unrelated to malaria, consult a healthcare provider for guidance.  \\n\\nAlways follow the full prescribing information and physician advice for specific medical contexts. Let me know if you need further clarification!","It looks like you&#x27;re asking about LOPRESSOR (metoprolol tartrate), but the provided context only contains information about **Atovaquone and Proguanil Hydrochloride** (an antimalarial medication). Unfortunately, I can&#x27;t extract details about LOPRESSOR from the given documents.  \\n\\nHowever, I can still help! If you&#x27;d like, I can provide general information about **common adverse reactions associated with metoprolol tartrate** (LOPRESSOR) based on my broader knowledge. Would you like me to do that?  \\n\\nIf instead you meant to ask about **Atovaquone and Proguanil Hydrochloride**, I can certainly summarize its adverse reactions from the provided context\\u2014just let me know!  \\n\\nFor accurate dosing or prescribing details, always refer to the full prescribing information or consult a healthcare provider. Let me know how I can best assist you!","Based on the provided context, there is no information about Metformin Hydrochloride tablets. The documents specifically discuss **Atovaquone and Proguanil Hydrochloride tablets**, including their initial U.S. approval in 2000, dosage, contraindications, and other details. \\n\\nFor information on Metformin Hydrochloride, you would need to consult its prescribing information or another reliable medical source. Let me know if you&#x27;d like assistance finding that! \\n\\n*Note:* If your symptoms are severe or worsening, seek medical attention promptly.","The provided context does not contain information about Metformin Hydrochloride tablets. The documents discuss **Atovaquone and Proguanil Hydrochloride tablets**, which were initially approved in the U.S. in **2000** (as stated in the context). However, there is no mention of Metformin Hydrochloride, its approval year, or pediatric dosing recommendations.  \\n\\nWould you like details about **Atovaquone and Proguanil Hydrochloride** instead? For example:  \\n- **Initial U.S. Approval**: 2000  \\n- **Pediatric Use**: Not explicitly detailed in the provided excerpts, but prophylaxis/treatment dosing for children typically follows weight-based guidelines (not covered here).  \\n\\nLet me know how I can assist further!","Based on the context provided, this appears to be prescribing information for **Atovaquone and Proguanil Hydrochloride tablets**, a medication approved in the U.S. in 2000 for:\\n\\n1. **Prevention (Prophylaxis) of Malaria** \\u2013 Specifically *Plasmodium falciparum* malaria, including in areas with chloroquine resistance.  \\n2. **Treatment of Acute, Uncomplicated Malaria** \\u2013 Effective in regions where other antimalarials (e.g., chloroquine, mefloquine) may fail due to drug resistance.  \\n\\n### Key Details:\\n- **Administration**: Taken daily with food or a milky drink. If vomiting occurs within 1 hour, a repeat dose is needed.  \\n- **Contraindications**: Severe renal impairment (for prophylaxis).  \\n- **Adverse Reactions**:  \\n  - *Prophylaxis*: Adults may experience diarrhea, headaches, or oral ulcers; pediatric patients report abdominal pain, vomiting, or cough.  \\n  - *Treatment*: Adolescents/adults may have nausea, dizziness, or weakness; children often experience vomiting or itching.  \\n- **Pregnancy**: Limited human data, but animal studies show no major fetal risks. Folate supplementation is advised due to proguanil\\u2019s mechanism.  \\n\\n### Safety Monitoring:\\n- **Drug Interactions**: Avoid concurrent use with rifampin/rifabutin (reduces efficacy); caution with anticoagulants (warfarin) due to increased bleeding risk.  \\n- **Lab Abnormalities**: Elevated liver enzymes observed in some patients during treatment.  \\n\\nThis summary is derived from the document\\u2019s \\"Highlights\\" and sections on dosage, adverse reactions, and contraindications. For comprehensive guidance, consult the full prescribing information.  \\n\\nNeed further specifics (e.g., dosing by weight, detailed side effects)? Just ask!"]],["reference_answer",["Metformin Hydrochloride tablets received initial U.S. approval in 1995.","The adult recommended starting dose for NORVASC for hypertension is 5 mg once daily, with a maximum dose of 10 mg once daily.","The warning associated with ZOLOFT is about suicidal thoughts and behaviors. It is important to see the full prescribing information for the complete boxed warning.","Albuterol sulfate inhalation solution should be administered from a jet nebulizer at an adequate flow rate, via a mouthpiece or face mask.","The warning associated with ZOLOFT is about suicidal thoughts and behaviors. It is important to closely monitor for clinical worsening and emergence of suicidal thoughts and behaviors when using ZOLOFT.","The dosage for adults is one adult strength tablet per day for prophylaxis and four adult strength tablets as a single daily dose for 3 days for treatment.","The most common adverse reactions associated with LOPRESSOR (metoprolol tartrate) tablets include tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, and rash.","Metformin Hydrochloride tablets received initial U.S. approval in 1995.","The initial U.S. approval year for Metformin Hydrochloride tablets is 1995 and the recommended starting dose for pediatric patients is 500 mg orally twice a day, with meals.","The warning associated with ZOLOFT is about suicidal thoughts and behaviors. It is important to closely monitor patients, especially pediatric and young adult patients, for clinical worsening and the emergence of suicidal thoughts and behaviors."]],["id",[3,4,8,6,8,9,5,3,3,8]],["content",["METFORMIN HYDROCHLORIDE- metformin hydrochloride tablet \\n \\nAmneal Pharmaceuticals LLC\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use \\nMETFORMIN\\nHYDROCHLORIDE TABLETS\\n safely and effectively. See full prescribing information for\\nMETFORMIN HYDROCHLORIDE TABLETS\\n. \\n \\nMETFORMIN HYDROCHLORIDE\\n tablets, for oral use \\nInitial U.S. Approval: 1995\\nWARNING: LACTIC ACIDOSIS\\nSee full prescribing information for complete boxed warning.\\nPostm...","NORVASC- amlodipine besylate tablet \\n \\nPFIZER LABORATORIES DIV PFIZER INC\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use NORVASC safely and\\neffectively. See full prescribing information for NORVASC. \\n \\nNORVASC\\n (amlodipine besylate) Tablets for oral administration \\nInitial U.S. Approval: 1992\\nINDICATIONS AND USAGE\\nNORVASC is a calcium channel blocker and may be used alone or in combination with other\\nantihypertensive and antiang...","ZOLOFT- sertraline hydrochloride tablet, film coated \\n \\nZOLOFT- sertraline hydrochloride solution, concentrate \\n \\nROERIG\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use ZOLOFT safely and\\neffectively. \\nSee full prescribing information for ZOLOFT.\\n \\nZOLOFT (sertraline hydrochloride) tablets, for oral use\\nZOLOFT (sertraline hydrochloride) oral solution\\nInitial U.S. Approval: 1991\\nWARNING: SUICIDAL THOUGHTS AND BEHAVIORS\\nSee full pre...","ALBUTEROL SULFATE- albuterol sulfate solution \\n \\nIngenus Pharmaceuticals, LLC\\n----------\\nAlbuterol Sulfate Inhalation Solution \\n0.63 mg*/3 mL and 1.25 mg*/3 mL \\n(*Equivalent to 0.75 mg of albuterol sulfate or 1.5 mg of albuterol sulfate per\\n3 mL)\\nPRESCRIBING INFORMATION\\nDESCRIPTION\\nAlbuterol sulfate inhalation solution is a sterile, clear, colorless solution of the sulfate salt\\nof racemic albuterol, albuterol sulfate. Albuterol sulfate is a relatively selective beta \\n-\\nadrenergic bronchodilator ...","ZOLOFT- sertraline hydrochloride tablet, film coated \\n \\nZOLOFT- sertraline hydrochloride solution, concentrate \\n \\nROERIG\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use ZOLOFT safely and\\neffectively. \\nSee full prescribing information for ZOLOFT.\\n \\nZOLOFT (sertraline hydrochloride) tablets, for oral use\\nZOLOFT (sertraline hydrochloride) oral solution\\nInitial U.S. Approval: 1991\\nWARNING: SUICIDAL THOUGHTS AND BEHAVIORS\\nSee full pre...","ATOVAQUONE AND PROGUANIL HCL- atovaquone and proguanil\\nhydrochloride tablet, film coated \\n \\nA-S Medication Solutions\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use Atovaquone and\\nProguanil Hydrochloride safely and effectively. See full prescribing information for\\nAtovaquone and Proguanil Hydrochloride.\\nAtovaquone and Proguanil Hydrochloride tablets\\nInitial U.S. Approval: 2000\\nINDICATIONS AND USAGE\\nAtovaquone and Proguanil Hydroc...","LOPRESSOR- metoprolol tartrate tablet \\n \\nValidus Pharmaceuticals LLC\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use \\nLOPRESSOR\\n safely and\\neffectively. See full prescribing information for \\nLOPRESSOR\\n. \\n      \\n \\nLOPRESSOR\\n (metoprolol \\ntart\\nr\\nate\\n) \\nt\\nablet\\ns\\n,\\n for \\no\\nral \\nu\\nse\\n \\nInitial U.S. Approval: \\n1992\\n \\nINDICATIONS AND USAGE\\nLOPRESSOR is a beta-adrenergic blocker indicated for the treatment of:\\nHypertension, to lower blo...","METFORMIN HYDROCHLORIDE- metformin hydrochloride tablet \\n \\nAmneal Pharmaceuticals LLC\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use \\nMETFORMIN\\nHYDROCHLORIDE TABLETS\\n safely and effectively. See full prescribing information for\\nMETFORMIN HYDROCHLORIDE TABLETS\\n. \\n \\nMETFORMIN HYDROCHLORIDE\\n tablets, for oral use \\nInitial U.S. Approval: 1995\\nWARNING: LACTIC ACIDOSIS\\nSee full prescribing information for complete boxed warning.\\nPostm...","METFORMIN HYDROCHLORIDE- metformin hydrochloride tablet \\n \\nAmneal Pharmaceuticals LLC\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use \\nMETFORMIN\\nHYDROCHLORIDE TABLETS\\n safely and effectively. See full prescribing information for\\nMETFORMIN HYDROCHLORIDE TABLETS\\n. \\n \\nMETFORMIN HYDROCHLORIDE\\n tablets, for oral use \\nInitial U.S. Approval: 1995\\nWARNING: LACTIC ACIDOSIS\\nSee full prescribing information for complete boxed warning.\\nPostm...","ZOLOFT- sertraline hydrochloride tablet, film coated \\n \\nZOLOFT- sertraline hydrochloride solution, concentrate \\n \\nROERIG\\n----------\\nHIGHLIGHTS OF PRESCRIBING INFORMATION\\nThese highlights do not include all the information needed to use ZOLOFT safely and\\neffectively. \\nSee full prescribing information for ZOLOFT.\\n \\nZOLOFT (sertraline hydrochloride) tablets, for oral use\\nZOLOFT (sertraline hydrochloride) oral solution\\nInitial U.S. Approval: 1991\\nWARNING: SUICIDAL THOUGHTS AND BEHAVIORS\\nSee full pre..."]],["color",["#ba0e0e","#0a980a","#ba0e0e","#ba0e0e","#ba0e0e","#0a980a","#0a980a","#ba0e0e","#ba0e0e","#ba0e0e"]]]}}},"view":{"type":"object","name":"CDSView","id":"p1326","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p1327"}}},"glyph":{"type":"object","name":"Scatter","id":"p1322","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.7},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p1323","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p1324","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p1340","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p1331","attributes":{"selected":{"type":"object","name":"Selection","id":"p1332","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p1333"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"uiucQTZfqkG15KBB/ZyjQdDgpEGFLJtBF2mrQQO+o0FRcpRB7nqVQQ=="},"shape":[10],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"LwFcQa7NV0GMeE9B45U+QUTfY0EJ3T1BNBI/QUrdLEGlx0tBe2hkQQ=="},"shape":[10],"dtype":"float32","order":"little"}]]}}},"view":{"type":"object","name":"CDSView","id":"p1341","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p1342"}}},"glyph":{"type":"object","name":"Scatter","id":"p1337","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.2}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p1338","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.1},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p1339","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.2}}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p1294","attributes":{"logo":"grey","tools":[{"type":"object","name":"PanTool","id":"p1309"},{"type":"object","name":"WheelZoomTool","id":"p1310","attributes":{"renderers":"auto"}},{"type":"object","name":"BoxZoomTool","id":"p1311","attributes":{"overlay":{"type":"object","name":"BoxAnnotation","id":"p1312","attributes":{"syncable":false,"level":"overlay","visible":false,"left":{"type":"number","value":"nan"},"right":{"type":"number","value":"nan"},"top":{"type":"number","value":"nan"},"bottom":{"type":"number","value":"nan"},"left_units":"canvas","right_units":"canvas","top_units":"canvas","bottom_units":"canvas","line_color":"black","line_alpha":1.0,"line_width":2,"line_dash":[4,4],"fill_color":"lightgrey","fill_alpha":0.5}}}},{"type":"object","name":"ResetTool","id":"p1317"},{"type":"object","name":"SaveTool","id":"p1318"},{"type":"object","name":"HoverTool","id":"p1285","attributes":{"renderers":[{"id":"p1325"}],"tooltips":"\\n    &lt;div style=\\"width:400px;\\"&gt;\\n    &lt;b&gt;Document id:&lt;/b&gt; @id &lt;br&gt;\\n    &lt;b&gt;Topic:&lt;/b&gt; @topic &lt;br&gt;\\n    &lt;b&gt;Question:&lt;/b&gt; @questions &lt;br&gt;\\n    &lt;b&gt;agent Answer:&lt;/b&gt; @agent_answer &lt;br&gt;\\n    &lt;b&gt;Reference Answer:&lt;/b&gt; @reference_answer &lt;br&gt;\\n    &lt;b&gt;Correctness:&lt;/b&gt; @correctness &lt;br&gt;\\n    &lt;b&gt;Content:&lt;/b&gt; @content\\n    &lt;/div&gt;\\n    "}}]}},"left":[{"type":"object","name":"LinearAxis","id":"p1304","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p1305","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p1306"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p1307"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p1299","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p1300","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p1301"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p1302"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p1303","attributes":{"axis":{"id":"p1299"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p1308","attributes":{"dimension":1,"axis":{"id":"p1304"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Legend","id":"p1328","attributes":{"title":"Question Correctness","title_text_color":"#B1B1B1","title_text_font_style":"bold","border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p1329","attributes":{"label":{"type":"value","value":"False"},"renderers":[{"id":"p1325"}],"index":0}},{"type":"object","name":"LegendItem","id":"p1330","attributes":{"label":{"type":"value","value":"True"},"renderers":[{"id":"p1325"}],"index":1}}]}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}}}],"tabs_location":"below"}}]}}';
        const render_items = [{"docid":"6310f847-ff16-4bca-a752-c47d52ed6673","roots":{"p1344":"c6e201dc-e398-4465-9549-672d472228fe"},"root_ids":["p1344"]}];
        root.Bokeh.embed.embed_items(docs_json, render_items);
        }
        if (root.Bokeh !== undefined) {
          embed_document(root);
        } else {
          let attempts = 0;
          const timer = setInterval(function(root) {
            if (root.Bokeh !== undefined) {
              clearInterval(timer);
              embed_document(root);
            } else {
              attempts++;
              if (attempts > 100) {
                clearInterval(timer);
                console.log("Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing");
              }
            }
          }, 10, root)
        }
      })(window);
    });
  };
  if (document.readyState != "loading") fn();
  else document.addEventListener("DOMContentLoaded", fn);
})();
    </script>

                <div id="c6e201dc-e398-4465-9549-672d472228fe" data-root-id="p1344" style="display: contents;"></div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">

                <div class="section-title">SELECTED METRICS</div>

                

            </div>
        </div>

        
    </div>
</div>



<script type="text/javascript">
    function opentab(evt, name) {
    // Declare all variables
    let i, tabcontent, tablinks;

    // Get all elements with class="tabcontent" and hide them
    tabcontent = document.getElementsByClassName("tabcontent");
    for (i = 0; i < tabcontent.length; i++) {
        tabcontent[i].style.display = "none";
    }

    // Get all elements with class="tablinks" and remove the class "active"
    tablinks = document.getElementsByClassName("tablinks");
    for (i = 0; i < tablinks.length; i++) {
        tablinks[i].className = tablinks[i].className.replace(" active", "");
    }

    // Show the current tab, and add an "active" class to the button that opened the tab
    document.getElementById(name).style.display = "block";
    evt.currentTarget.className += " active";
}
</script>
